Home » Archive

Articles tagged with: Preclinical Studies

Featured »

Posted on 9 Mar 2013 | 3,547 views
Long Term Crash on Biotech OXiGENE – OXGN up Over 200% in 9 Trading Days

OXiGENE (Stock Symbol: OXGN) climbed over 14% to $5.60 per share on May 12, 2011, with volume soaring to more than 10 million shares trading hands, up from its average daily volume of just 892,077 shares. The “Biotech” company announced Thursday morning that it had commenced “Phase 1 Trials” of an anticancer compound used the treatment of patients with acute myelogenous Leukemia.